|
The most comprehensive analysis on the various treatments, challenges and players driving the vital diabetes market.
Published by the editors of BioWorld Today and Medical Device Daily, The Diabetes Report 2008: Developments and Opportunities in Drugs and Devices provides you with an in-depth understanding of the therapeutic and venture landscapes for the diabetes drug and device markets. By identifying the key drug and device technologies being researched, this report gives you the ability to spot new opportunities for product development and gauge which therapies are currently driving the market.
Diabetes is the fastest growing disease in the U.S., afflicting 7% of the population and using 34% of the Medicare budget. Diabetes affects at least 171 million people worldwide, and is expected to more than double within the next two decades, but many key therapeutic problems in the management of diabetes still exist.
Yet, with these challenges come opportunities for many drug and device
companies to exploit the large market potential, while addressing the epidemic
implications on public health and spiraling health care costs.
The Diabetes Report 2008 is priced at $599, plus $17.95 in shipping and handling.
You can review this product for 30 days. If you cancel within 30 days of receipt, you will receive a full credit upon return of the product together with a request for cancellation.
The Diabetes Report 2008 reviews the most active therapeutic areas and provides an in-depth study into research activity and company developments for each, including:
- Combination Therapies
- Glucagon-Like Peptide 1
- DPP-IV Inhibitors
- PPARs and Insulin Sensitizers
- SGLT Inhibitors
- Meglitinides
- Monoclonal Antibodies
- Glucokinase Activators
- Glucose Inhibition and Control
- Beta Cells and hESCs
- Insulin and Insulin Delivery
- Glucose Monitoring Devices
- And many other research areas
Sections on predicting diabetes and diabetes software also are included in the report.
The Diabetes Report 2008 evaluates the progress companies have made in the creation and delivery of these therapies to manage diabetes and gauges the current and future capacities of biotechnology, pharmaceutical and device companies developing new products and services. With this report, you will be able to:
- See which current and future therapies will drive the industry.
- Identify the key companies making an impact in diabetes research.
- Evaluate which drugs and device technologies will likely reach the market.
- Spot research opportunities in different therapeutic areas.
- Understand the key obstacles and restraints companies face in the diabetes space.
- Recognize related technologies and indications that impact diabetes R&D.
- Utilize statistical charts on prevalence, costs, venture prospects and more.
The Diabetes Report 2008: Developments and Opportunities in Drugs and Devices is a must-have for any biotechnology, pharmaceutical or medical device company directly involved in the diabetes market, as well as for those with a speculative interest in this prolific sector.
This report can be purchased in print or PDF.
To view the table of contents, click here.
|
Print and PDF Version:
|
|
Report-Only Price: $599 + ($17.95 s&h)
|
Order Now
|
|
